Biotechs test IPO market despite concerns over Robert Kennedy’s health role
- Posted on November 25, 2024
- By Financial Times
- 1 Views
Biotechs test IPO market despite concerns over Robert Kennedy’s health role
Trump nominee has caused concern in the industry due to his desire to reduce spending on medicines
